Company Profile
etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of eClinical software and services to pharmaceutical, biotechnology, medical device, and contract research organizations (CROs) offers adaptive, Web-based tools that work together to coordinate data capture, logistics, patient interaction and trial management—turning data into intelligence and shortening the pathway to an actionable study endpoint.
With global operations, etrials is the only top tier solutions provider to offer electronic data capture (EDC), interactive voice response (IVR), and electronic patient diaries (eDiary) as part of an integrated software as a service (SaaS) platform or as individual solutions to optimize clinical trials. This unique integration platform enables our customers to select one or more solutions for their clinical trial and assures that information will integrate seamlessly and easily.
As an experienced leader, etrials has facilitated over 900 trials involving more than 400,000 patients in 60 countries; and has participated in 33 studies used for new drug applications. Having partnered with over 100 clients, including 16 of the top 20 global pharmaceutical companies and top CROs, etrials is leading the way towards Adaptive Trials and integration between eClinical and electronic health records.
Please contact the etrials Investor Relations team with any questions or for more information:
|
Chris Sakell chris.sakell@etrials.com (919) 653-3648 Acquisition FAQs |
Recent Releases
Jun 22, 2009
etrials Worldwide Introduces New eClinical Capabilities At DIA's 45th Annual Meeting in San Diego
Jun 16, 2009
Merge Healthcare Commences Exchange Offer for etrials Worldwide, Inc. Shares
Events
May 12, 2009
etrials Worldwide 1st Qtr 2009 Financial Results
Mar 5, 2009
etrials Worldwide 4th Qtr 2008 Financial Results